{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:37:54Z","timestamp":1792798674202,"version":"4.5.0"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,2,14]],"date-time":"2020-02-14T00:00:00Z","timestamp":1581638400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,2,14]],"date-time":"2020-02-14T00:00:00Z","timestamp":1581638400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["HHSN261200800001E"],"award-info":[{"award-number":["HHSN261200800001E"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["CA78527"],"award-info":[{"award-number":["CA78527"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    HPV16 causes half of cervical cancers worldwide; for unknown reasons, most infections resolve within two years. Here, we analyze the viral genomes of 5,328 HPV16-positive case-control samples to investigate mutational signatures and the role of human APOBEC3-induced mutations in viral clearance and cervical carcinogenesis. We identify four de novo mutational signatures, one of which matches the COSMIC APOBEC-associated signature 2. The viral genomes of the precancer\/cancer cases are less likely to contain within-host somatic HPV16 APOBEC3-induced mutations\u00a0(Fisher\u2019s exact test,\n                    <jats:italic>P<\/jats:italic>\n                    = 6.2 x 10\n                    <jats:sup>\u221214<\/jats:sup>\n                    ), and have a 30% lower nonsynonymous APOBEC3 mutation burden compared to controls. We replicate the low prevalence of HPV16 APOBEC3-induced mutations in 1,749 additional cases. APOBEC3 mutations also historically contribute to the evolution of HPV16 lineages. We demonstrate that cervical infections with a greater burden of somatic HPV16 APOBEC3-induced mutations are more likely to be benign or subsequently clear, suggesting they may reduce persistence, and thus progression, within the host.\n                  <\/jats:p>","DOI":"10.1038\/s41467-020-14730-1","type":"journal-article","created":{"date-parts":[[2020,2,14]],"date-time":"2020-02-14T06:03:14Z","timestamp":1581660194000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":73,"title":["Mutations in the HPV16 genome induced by APOBEC3 are associated with viral clearance"],"prefix":"10.1038","volume":"11","author":[{"given":"Bin","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanzi","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meredith","family":"Yeager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7534-333X","authenticated-orcid":false,"given":"Gary","family":"Clifford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Wentzensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Cullen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2762-190X","authenticated-orcid":false,"given":"Joseph F.","family":"Boland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Bass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mia K.","family":"Steinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Raine-Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DongHyuk","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert D.","family":"Burk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maisa","family":"Pinheiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2234-0631","authenticated-orcid":false,"given":"Michael","family":"Dean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6287-1598","authenticated-orcid":false,"given":"Chase W.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurie","family":"Burdett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Roberson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Lorey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Franceschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip E.","family":"Castle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosemary","family":"Zuna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Schiffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Mirabello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,14]]},"reference":[{"key":"14730_CR1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","volume":"189","author":"JMM Walboomers","year":"1999","unstructured":"Walboomers, J. M. M. et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 189, 12\u201319 (1999).","journal-title":"J. Pathol."},{"key":"14730_CR2","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1016\/S1470-2045(14)70471-1","volume":"15","author":"C Ndiaye","year":"2014","unstructured":"Ndiaye, C. et al. HPV DNA, E6\/E7 mRNA, and p16INK4a detection in head and neck cancers: a systematic review and meta-analysis. Lancet Oncol. 15, 1319\u20131331 (2014).","journal-title":"Lancet Oncol."},{"key":"14730_CR3","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.pvr.2015.06.003","volume":"1","author":"S Hartwig","year":"2015","unstructured":"Hartwig, S. et al. Estimation of the epidemiological burden of HPV-related anogenital cancers, precancerous lesions, and genital warts in women and men in Europe: potential additional benefit of a nine-valent second generation HPV vaccine compared to first generation HPV vaccines. Papillomavirus Res. 1, 90\u2013100 (2015).","journal-title":"Papillomavirus Res."},{"key":"14730_CR4","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1001\/jamaoncol.2015.0735","volume":"1","author":"Global Burden of Disease Cancer Collaboration.","year":"2015","unstructured":"Global Burden of Disease Cancer Collaboration. The global burden of cancer 2013. JAMA Oncol. 1, 505\u2013527 (2015).","journal-title":"JAMA Oncol."},{"key":"14730_CR5","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/S1470-2045(10)70230-8","volume":"11","author":"S de Sanjose","year":"2010","unstructured":"de Sanjose, S. et al. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol. 11, 1048\u20131056 (2010).","journal-title":"Lancet Oncol."},{"key":"14730_CR6","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1002\/ijc.27485","volume":"131","author":"P Guan","year":"2012","unstructured":"Guan, P. et al. Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer. Int J. Cancer 131, 2349\u20132359 (2012).","journal-title":"Int J. Cancer"},{"key":"14730_CR7","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/S1470-2045(08)70103-7","volume":"9","author":"M McCredie","year":"2008","unstructured":"McCredie, M. et al. Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study. Lancet Oncol. 9, 425\u2013434 (2008).","journal-title":"Lancet Oncol."},{"key":"14730_CR8","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1093\/jnci\/djq356","volume":"102","author":"SK Kj\u00e6r","year":"2010","unstructured":"Kj\u00e6r, S. K., Frederiksen, K., Munk, C. & Iftner, T. Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence. J. Natl Cancer Inst. 102, 1478\u20131488 (2010).","journal-title":"J. Natl Cancer Inst."},{"key":"14730_CR9","doi-asserted-by":"publisher","first-page":"16086","DOI":"10.1038\/nrdp.2016.86","volume":"2","author":"M Schiffman","year":"2016","unstructured":"Schiffman, M. et al. Carcinogenic human papillomavirus infection. Nat. Rev. Dis. Prim. 2, 16086 (2016).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"14730_CR10","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1093\/jnci\/93.4.315","volume":"93","author":"A Hildesheim","year":"2001","unstructured":"Hildesheim, A. et al. Human papillomavirus type 16 variants and risk of cervical cancer. J. Natl Cancer Inst. 93, 315\u2013318 (2001).","journal-title":"J. Natl Cancer Inst."},{"key":"14730_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/1743-422X-10-30","volume":"10","author":"C Pientong","year":"2013","unstructured":"Pientong, C. et al. Association of human papillomavirus type 16 long control region mutation and cervical cancer. Virol. J. 10, 30 (2013).","journal-title":"Virol. J."},{"key":"14730_CR12","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1158\/1055-9965.EPI-06-0670","volume":"16","author":"LF Xi","year":"2007","unstructured":"Xi, L. F. et al. Risk for high-grade cervical intraepithelial neoplasia associated with variants of human papillomavirus types 16 and 18. Cancer Epidemiol. Biomark. Prev. 16, 4\u201310 (2007).","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"14730_CR13","doi-asserted-by":"publisher","first-page":"3159","DOI":"10.1158\/0008-5472.CAN-09-4179","volume":"70","author":"M Schiffman","year":"2010","unstructured":"Schiffman, M. et al. A population-based prospective study of carcinogenic human papillomavirus variant lineages, viral persistence, and cervical neoplasia. Cancer Res. 70, 3159\u20133169 (2010).","journal-title":"Cancer Res."},{"key":"14730_CR14","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1038\/bjc.2012.508","volume":"108","author":"I Cornet","year":"2013","unstructured":"Cornet, I. et al. HPV16 genetic variation and the development of cervical cancer worldwide. Br. J. Cancer 108, 240\u2013244 (2013).","journal-title":"Br. J. Cancer"},{"key":"14730_CR15","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1158\/1055-9965.EPI-10-1187","volume":"20","author":"T Gheit","year":"2011","unstructured":"Gheit, T. et al. Risks for persistence and progression by human papillomavirus type 16 variant lineages among a population-based sample of Danish women. Cancer Epidemiol. Biomark. Prev. 20, 1315\u20131321 (2011).","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"14730_CR16","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1016\/S0140-6736(05)61263-9","volume":"352","author":"I Zehbe","year":"1998","unstructured":"Zehbe, I., Voglino, G., Delius, H., Wilander, E. & Tommasino, M. Risk of cervical cancer and geographical variations of human papillomavirus 16 E6 polymorphisms. Lancet 352, 1441\u20131442 (1998).","journal-title":"Lancet"},{"key":"14730_CR17","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1002\/ijc.24706","volume":"125","author":"RE Zuna","year":"2009","unstructured":"Zuna, R. E. et al. Association of HPV16 E6 variants with diagnostic severity in cervical cytology samples of 354 women in a US population. Int. J. Cancer 125, 2609\u20132613 (2009).","journal-title":"Int. J. Cancer"},{"key":"14730_CR18","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1002\/ijc.22481","volume":"120","author":"L Sichero","year":"2007","unstructured":"Sichero, L. et al. High grade cervical lesions are caused preferentially by non-European variants of HPVs 16 and 18. Int. J. Cancer 120, 1763\u20131768 (2007).","journal-title":"Int. J. Cancer"},{"key":"14730_CR19","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1093\/jnci\/93.17.1325","volume":"93","author":"J Berumen","year":"2001","unstructured":"Berumen, J. et al. Asian-American variants of human papillomavirus 16 and risk for cervical cancer: a case\u2013control study. J. Natl Cancer Inst. 93, 1325\u20131330 (2001).","journal-title":"J. Natl Cancer Inst."},{"key":"14730_CR20","doi-asserted-by":"publisher","first-page":"e100746","DOI":"10.1371\/journal.pone.0100746","volume":"9","author":"LB Freitas","year":"2014","unstructured":"Freitas, L. B. et al. Human papillomavirus 16 non-european variants are preferentially associated with high-grade cervical lesions. PLoS ONE 9, e100746 (2014).","journal-title":"PLoS ONE"},{"key":"14730_CR21","doi-asserted-by":"publisher","first-page":"djw100","DOI":"10.1093\/jnci\/djw100","volume":"108","author":"L Mirabello","year":"2016","unstructured":"Mirabello, L. et al. HPV16 sublineage associations with histology-specific cancer risk using HPV whole-genome sequences in 3200 women. J. Natl Cancer Inst. 108, djw100 (2016).","journal-title":"J. Natl Cancer Inst."},{"key":"14730_CR22","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3390\/v10020080","volume":"10","author":"L Mirabello","year":"2018","unstructured":"Mirabello, L. et al. The intersection of HPV epidemiology, genomics and mechanistic studies of HPV-mediated carcinogenesis. Viruses 10, 80 (2018).","journal-title":"Viruses"},{"key":"14730_CR23","doi-asserted-by":"publisher","first-page":"e00844-17","DOI":"10.1128\/JVI.00844-17","volume":"91","author":"P van der Weele","year":"2017","unstructured":"van der Weele, P., Meijer, C. J. L. M. & King, A. J. Whole-genome sequencing and variant analysis of human papillomavirus 16 infections. J. Virol. 91, e00844-17 (2017).","journal-title":"J. Virol."},{"key":"14730_CR24","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1016\/j.cell.2017.08.001","volume":"170","author":"L Mirabello","year":"2017","unstructured":"Mirabello, L. et al. HPV16 E7 genetic conservation is critical to carcinogenesis. Cell 170, 1164\u20131174.e6 (2017).","journal-title":"Cell"},{"key":"14730_CR25","doi-asserted-by":"publisher","first-page":"e00017","DOI":"10.1128\/JVI.00017-18","volume":"92","author":"Y Hirose","year":"2018","unstructured":"Hirose, Y. et al. Within-host variations of human papillomavirus reveal APOBEC signature mutagenesis in the viral genome. J. Virol. 92, e00017\u2013e00018 (2018).","journal-title":"J. Virol."},{"key":"14730_CR26","doi-asserted-by":"publisher","first-page":"2624","DOI":"10.3390\/v5112624","volume":"5","author":"A Amador-Molina","year":"2013","unstructured":"Amador-Molina, A., Hern\u00e1ndez-Valencia, J. F., Lamoyi, E., Contreras-Paredes, A. & Lizano, M. Role of innate immunity against human papillomavirus (HPV) infections and effect of adjuvants in promoting specific immune response. Viruses 5, 2624\u20132642 (2013).","journal-title":"Viruses"},{"key":"14730_CR27","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.bbrc.2015.03.068","volume":"460","author":"S Mori","year":"2015","unstructured":"Mori, S., Takeuchi, T., Ishii, Y. & Kukimoto, I. Identification of APOBEC3B promoter elements responsible for activation by human papillomavirus type 16 E6. Biochem. Biophys. Res. Commun. 460, 555\u2013560 (2015).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"14730_CR28","doi-asserted-by":"crossref","unstructured":"Mori, S. et al. Human papillomavirus 16 E6 upregulates APOBEC3B via the TEAD transcription factor. J. Virol. 91, e02413-16 (2017).","DOI":"10.1128\/JVI.02413-16"},{"key":"14730_CR29","doi-asserted-by":"crossref","unstructured":"Vieira, V. C. et al. Human papillomavirus E6 triggers upregulation of the antiviral and cancer genomic DNA deaminase APOBEC3B. MBio 5, e02234-14 (2014).","DOI":"10.1128\/mBio.02234-14"},{"key":"14730_CR30","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1128\/JVI.02383-14","volume":"89","author":"CJ Warren","year":"2015","unstructured":"Warren, C. J. et al. APOBEC3A functions as a restriction factor of human papillomavirus. J. Virol. 89, 688\u2013702 (2015).","journal-title":"J. Virol."},{"key":"14730_CR31","doi-asserted-by":"publisher","first-page":"11056","DOI":"10.1093\/nar\/gkx721","volume":"45","author":"M Periyasamy","year":"2017","unstructured":"Periyasamy, M. et al. p53 controls expression of the DNA deaminase APOBEC3B to limit its potential mutagenic activity in cancer cells. Nucleic Acids Res. 45, 11056\u201311069 (2017).","journal-title":"Nucleic Acids Res."},{"key":"14730_CR32","doi-asserted-by":"publisher","first-page":"R269","DOI":"10.1530\/JME-19-0011","volume":"62","author":"NJ Smith","year":"2019","unstructured":"Smith, N. J. & Fenton, T. R. The APOBEC3 genes and their role in cancer: insights from human papillomavirus. J. Mol. Endocrinol. 62, R269\u2013R287 (2019).","journal-title":"J. Mol. Endocrinol."},{"key":"14730_CR33","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.jgg.2017.04.009","volume":"44","author":"B Yang","year":"2017","unstructured":"Yang, B., Li, X. S., Lei, L. Q. & Chen, J. APOBEC: from mutator to editor. J. Genet. Genomics 44, 423\u2013437 (2017).","journal-title":"J. Genet. Genomics"},{"key":"14730_CR34","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1016\/S1097-2765(02)00742-6","volume":"10","author":"RS Harris","year":"2002","unstructured":"Harris, R. S., Petersen-Mahrt, S. K. & Neuberger, M. S. RNA editing enzyme APOBEC1 and some of its homologs can act as DNA mutators. Mol. Cell 10, 1247\u20131253 (2002).","journal-title":"Mol. Cell"},{"key":"14730_CR35","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/nature21386","volume":"543","author":"N The Cancer Genome Atlas Research","year":"2017","unstructured":"The Cancer Genome Atlas Research, N. et al. Integrated genomic and molecular characterization of cervical cancer. Nature 543, 378\u2013384 (2017).","journal-title":"Nature"},{"key":"14730_CR36","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/j.cell.2012.04.024","volume":"149","author":"S Nik-Zainal","year":"2012","unstructured":"Nik-Zainal, S. et al. Mutational processes molding the genomes of 21 breast cancers. Cell 149, 979\u2013993 (2012).","journal-title":"Cell"},{"key":"14730_CR37","doi-asserted-by":"publisher","first-page":"11283","DOI":"10.1073\/pnas.1607606113","volume":"113","author":"H Zheng","year":"2016","unstructured":"Zheng, H. et al. Whole-exome sequencing identifies multiple loss-of-function mutations of NF-kappaB pathway regulators in nasopharyngeal carcinoma. Proc. Natl Acad. Sci. USA 113, 11283\u201311288 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"14730_CR38","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nature17676","volume":"534","author":"S Nik-Zainal","year":"2016","unstructured":"Nik-Zainal, S. et al. Landscape of somatic mutations in 560 breast cancer whole-genome sequences. Nature 534, 47\u201354 (2016).","journal-title":"Nature"},{"key":"14730_CR39","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nature12477","volume":"500","author":"LB Alexandrov","year":"2013","unstructured":"Alexandrov, L. B. et al. Signatures of mutational processes in human cancer. Nature 500, 415 (2013).","journal-title":"Nature"},{"key":"14730_CR40","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1038\/ng.2702","volume":"45","author":"SA Roberts","year":"2013","unstructured":"Roberts, S. A. et al. An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers. Nat. Genet. 45, 970\u2013976 (2013).","journal-title":"Nat. Genet"},{"key":"14730_CR41","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1038\/ng.2701","volume":"45","author":"MB Burns","year":"2013","unstructured":"Burns, M. B., Temiz, N. A. & Harris, R. S. Evidence for APOBEC3B mutagenesis in multiple human cancers. Nat. Genet. 45, 977 (2013).","journal-title":"Nat. Genet."},{"key":"14730_CR42","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/nature14129","volume":"517","author":"The Cancer Genome Atlas, N.","year":"2015","unstructured":"The Cancer Genome Atlas, N. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature 517, 576\u2013582 (2015).","journal-title":"Nature"},{"key":"14730_CR43","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1016\/j.celrep.2014.05.012","volume":"7","author":"S Henderson","year":"2014","unstructured":"Henderson, S., Chakravarthy, A., Su, X., Boshoff, C. & Fenton, T. R. APOBEC-mediated cytosine deamination links PIK3CA helical domain mutations to human papillomavirus-driven tumor development. Cell Rep. 7, 1833\u20131841 (2014).","journal-title":"Cell Rep."},{"key":"14730_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1101\/gr.241141.118","volume":"29","author":"ML Gillison","year":"2019","unstructured":"Gillison, M. L. et al. Human papillomavirus and the landscape of secondary genetic alterations in oral cancers. Genome Res. 29, 1\u201317 (2019).","journal-title":"Genome Res."},{"issue":"6447","key":"14730_CR45","doi-asserted-by":"publisher","first-page":"eaaw2872","DOI":"10.1126\/science.aaw2872","volume":"364","author":"R\u00e9mi Buisson","year":"2019","unstructured":"Buisson, R. et al. Passenger hotspot mutations in cancer driven by APOBEC3A and mesoscale genomic features. Science 364, eaaw2872 (2019).","journal-title":"Science"},{"key":"14730_CR46","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1158\/2159-8290.CD-15-0344","volume":"5","author":"C Swanton","year":"2015","unstructured":"Swanton, C., McGranahan, N., Starrett, G. J. & Harris, R. S. APOBEC enzymes: mutagenic fuel for cancer evolution and heterogeneity. Cancer Discov. 5, 704\u2013712 (2015).","journal-title":"Cancer Discov."},{"key":"14730_CR47","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.molmed.2015.02.007","volume":"21","author":"S Henderson","year":"2015","unstructured":"Henderson, S. & Fenton, T. APOBEC3 genes: retroviral restriction factors to cancer drivers. Trends Mol. Med. 21, 274\u2013284 (2015).","journal-title":"Trends Mol. Med"},{"key":"14730_CR48","doi-asserted-by":"publisher","first-page":"102","DOI":"10.4103\/2319-4170.148904","volume":"38","author":"MB Burns","year":"2015","unstructured":"Burns, M. B., Leonard, B. & Harris, R. S. APOBEC3B: pathological consequences of an innate immune DNA mutator. Biomed. J. 38, 102\u2013110 (2015).","journal-title":"Biomed. J."},{"key":"14730_CR49","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1038\/nrc3816","volume":"14","author":"SA Roberts","year":"2014","unstructured":"Roberts, S. A. & Gordenin, D. A. Hypermutation in human cancer genomes: footprints and mechanisms. Nat. Rev. Cancer 14, 786\u2013800 (2014).","journal-title":"Nat. Rev. Cancer"},{"key":"14730_CR50","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3390\/v9080233","volume":"9","author":"CJ Warren","year":"2017","unstructured":"Warren, C. J., Westrich, J. A., Van Doorslaer, K. & Pyeon, D. Roles of APOBEC3A and APOBEC3B in human papillomavirus infection and disease progression. Viruses 9, 233 (2017).","journal-title":"Viruses"},{"key":"14730_CR51","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nature01709","volume":"424","author":"B Mangeat","year":"2003","unstructured":"Mangeat, B. et al. Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts. Nature 424, 99\u2013103 (2003).","journal-title":"Nature"},{"key":"14730_CR52","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1126\/science.1153201","volume":"320","author":"J Vartanian","year":"2008","unstructured":"Vartanian, J., Gu\u00e9tard, D., Henry, M. & Wain-Hobson, S. Evidence for editing of human papillomavirus DNA by APOBEC3 in benign and precancerous lesions. Science 320, 230\u2013233 (2008).","journal-title":"Science"},{"key":"14730_CR53","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1002\/jmv.24215","volume":"87","author":"I Kukimoto","year":"2015","unstructured":"Kukimoto, I. et al. Hypermutation in the E2 gene of human papillomavirus type 16 in cervical intraepithelial neoplasia. J. Med. Virol. 87, 1754\u20131760 (2015).","journal-title":"J. Med. Virol."},{"key":"14730_CR54","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.virol.2015.08.017","volume":"485","author":"K Wakae","year":"2015","unstructured":"Wakae, K. et al. Detection of hypermutated human papillomavirus type 16 genome by Next-Generation Sequencing. Virology 485, 460\u2013466 (2015).","journal-title":"Virology"},{"key":"14730_CR55","doi-asserted-by":"crossref","unstructured":"Warren, C. J., Pyeon, D., Van Doorslaer, K., Pandey, A. & Espinosa, J. M. Role of the host restriction factor APOBEC3 on papillomavirus evolution. Virus Evol. 1, pii: vev015 (2015).","DOI":"10.1093\/ve\/vev015"},{"key":"14730_CR56","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1158\/1055-9965.EPI-10-1267","volume":"20","author":"P Castle","year":"2011","unstructured":"Castle, P. et al. Human papillomavirus (HPV) genotypes in women with cervical precancer and cancer at Kaiser Permanente Northern California. Cancer Epidemiol. Biomark. Prev. 20, 946\u2013953 (2011).","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"14730_CR57","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1002\/ijc.24528","volume":"125","author":"N Wentzensen","year":"2009","unstructured":"Wentzensen, N. et al. Multiple human papillomavirus genotype infections in cervical cancer progression in the study to understand cervical cancer early endpoints and determinants. Int. J. Cancer 125, 2151\u20132158 (2009).","journal-title":"Int. J. Cancer"},{"key":"14730_CR58","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1158\/1055-9965.EPI-08-0591","volume":"18","author":"SS Wang","year":"2009","unstructured":"Wang, S. S. et al. Human papillomavirus (HPV) cofactors by disease progression and HPV types in the Study to Understand Cervical Cancer Early Endpoints and Determinants (SUCCEED). Cancer Epidemiol., Biomark. Prev. 18, 113\u2013120 (2009).","journal-title":"Cancer Epidemiol., Biomark. Prev."},{"key":"14730_CR59","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1002\/ijc.23969","volume":"124","author":"N Wentzensen","year":"2009","unstructured":"Wentzensen, N. et al. Grading the severity of cervical neoplasia based on combined histopathology, cytopathology, and HPV genotype distribution among 1,700 women referred to colposcopy in Oklahoma. Int. J. Cancer 124, 964\u2013969 (2009).","journal-title":"Int. J. Cancer"},{"key":"14730_CR60","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1093\/jnci\/87.11.796","volume":"87","author":"FX Bosch","year":"1995","unstructured":"Bosch, F. X. et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J. Natl Cancer Inst. 87, 796\u2013802 (1995).","journal-title":"J. Natl Cancer Inst."},{"key":"14730_CR61","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1056\/NEJMoa021641","volume":"348","author":"N Mu\u00f1oz","year":"2003","unstructured":"Mu\u00f1oz, N. et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N. Engl. J. Med. 348, 518\u2013527 (2003).","journal-title":"N. Engl. J. Med."},{"key":"14730_CR62","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/S0140-6736(05)67069-9","volume":"366","author":"GM Clifford","year":"2005","unstructured":"Clifford, G. M. et al. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet 366, 991\u2013998 (2005).","journal-title":"Lancet"},{"key":"14730_CR63","doi-asserted-by":"crossref","unstructured":"Crosbie, E. J., Einstein, M. H., Franceschi, S. & Kitchener, H.C. Human papillomavirus and cervical cancer. Lancet 382, 889\u2013899 (2013).","DOI":"10.1016\/S0140-6736(13)60022-7"},{"key":"14730_CR64","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.pvr.2015.05.004","volume":"1","author":"M Cullen","year":"2015","unstructured":"Cullen, M. et al. Deep sequencing of HPV16 genomes: a new high-throughput tool for exploring the carcinogenicity and natural history of HPV16 infection. Papillomavirus Res. 1, 3\u201311 (2015).","journal-title":"Papillomavirus Res."},{"key":"14730_CR65","doi-asserted-by":"publisher","first-page":"D941","DOI":"10.1093\/nar\/gky1015","volume":"47","author":"JG Tate","year":"2018","unstructured":"Tate, J. G. et al. COSMIC: the catalogue of somatic mutations in cancer. Nucleic Acids Res. 47, D941\u2013D947 (2018).","journal-title":"Nucleic Acids Res."},{"key":"14730_CR66","volume-title":"Fundamentals of Molecular Evolution","author":"D Graur","year":"2000","unstructured":"Graur, D. & Li, W.-H. Fundamentals of Molecular Evolution (Sinauer Associates, Inc, Sanderland, MA, 2000)."},{"key":"14730_CR67","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1038\/ng.3378","volume":"47","author":"K Chan","year":"2015","unstructured":"Chan, K. et al. An APOBEC3A hypermutation signature is distinguishable from the signature of background mutagenesis by APOBEC3B in human cancers. Nat. Genet. 47, 1067\u20131072 (2015).","journal-title":"Nat. Genet."},{"key":"14730_CR68","doi-asserted-by":"publisher","first-page":"e21375","DOI":"10.1371\/journal.pone.0021375","volume":"6","author":"B Smith","year":"2011","unstructured":"Smith, B. et al. Sequence imputation of HPV16 genomes for genetic association studies. PLoS ONE 6, e21375 (2011).","journal-title":"PLoS ONE"},{"key":"14730_CR69","doi-asserted-by":"publisher","first-page":"F55","DOI":"10.1016\/j.vaccine.2012.06.083","volume":"30","author":"J Doorbar","year":"2012","unstructured":"Doorbar, J. et al. The biology and life-cycle of human papillomaviruses. Vaccine 30, F55\u2013F70 (2012).","journal-title":"Vaccine"},{"key":"14730_CR70","doi-asserted-by":"publisher","first-page":"39385","DOI":"10.18632\/oncotarget.6324","volume":"6","author":"CJ Warren","year":"2015","unstructured":"Warren, C. J. & Pyeon, D. APOBEC3 in papillomavirus restriction, evolution and cancer progression. Oncotarget 6, 39385\u201339386 (2015).","journal-title":"Oncotarget"},{"key":"14730_CR71","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.virol.2013.07.018","volume":"445","author":"RD Burk","year":"2013","unstructured":"Burk, R. D., Harari, A. & Chen, Z. Human papillomavirus genome variants. Virology 445, 232\u2013243 (2013).","journal-title":"Virology"},{"key":"14730_CR72","doi-asserted-by":"publisher","first-page":"e1006211","DOI":"10.1371\/journal.ppat.1006211","volume":"13","author":"AA McBride","year":"2017","unstructured":"McBride, A. A. & Warburton, A. The role of integration in oncogenic progression of HPV-associated cancers. PLoS Pathog. 13, e1006211 (2017).","journal-title":"PLoS Pathog."},{"key":"14730_CR73","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1158\/1055-9965.EPI-12-0905","volume":"21","author":"MA Clarke","year":"2012","unstructured":"Clarke, M. A. et al. Human papillomavirus DNA Methylation as a potential biomarker for cervical cancer. Cancer Epidemiol. Biomark. Prev. 21, 2125\u20132137 (2012).","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"14730_CR74","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1002\/ijc.27750","volume":"132","author":"L Mirabello","year":"2013","unstructured":"Mirabello, L. et al. Elevated methylation of HPV16 DNA is associated with the development of high grade cervical intraepithelial neoplasia. Int J. Cancer 132, 1412\u20131422 (2013).","journal-title":"Int J. Cancer"},{"key":"14730_CR75","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1084\/jem.20051512","volume":"203","author":"G Peng","year":"2006","unstructured":"Peng, G., Lei, K. J., Jin, W., Greenwell-Wild, T. & Wahl, S. M. Induction of APOBEC3 family proteins, a defensive maneuver underlying interferon-induced anti-HIV-1 activity. J. Exp. Med. 203, 41\u201346 (2006).","journal-title":"J. Exp. Med."},{"key":"14730_CR76","doi-asserted-by":"publisher","first-page":"9474","DOI":"10.1128\/JVI.01089-09","volume":"83","author":"FA Koning","year":"2009","unstructured":"Koning, F. A. et al. Defining APOBEC3 expression patterns in human tissues and hematopoietic cell subsets. J. Virol. 83, 9474\u20139485 (2009).","journal-title":"J. Virol."},{"key":"14730_CR77","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1016\/j.bbrc.2016.08.148","volume":"478","author":"W Maruyama","year":"2016","unstructured":"Maruyama, W. et al. Classical NF-\u03baB pathway is responsible for APOBEC3B expression in cancer cells. Biochem. Biophys. Res. Commun. 478, 1466\u20131471 (2016).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"14730_CR78","first-page":"4538","volume":"75","author":"B Leonard","year":"2015","unstructured":"Leonard, B. et al. The PKC\/NF-\u03baB signaling pathway induces APOBEC3B expression in multiple human. Cancers 75, 4538\u20134547 (2015).","journal-title":"Cancers"},{"key":"14730_CR79","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1158\/1541-7786.MCR-17-0019","volume":"15","author":"D Menendez","year":"2017","unstructured":"Menendez, D., Nguyen, T.-A., Snipe, J. & Resnick, M. A. The cytidine deaminase APOBEC3 family is subject to transcriptional regulation by p53. Mol. Cancer Res. 15, 735\u2013743 (2017).","journal-title":"Mol. Cancer Res."},{"key":"14730_CR80","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1038\/ng.3670","volume":"48","author":"CD Middlebrooks","year":"2016","unstructured":"Middlebrooks, C. D. et al. Association of germline variants in the APOBEC3 region with cancer risk and enrichment with APOBEC-signature mutations in tumors. Nat. Genet. 48, 1330\u20131338 (2016).","journal-title":"Nat. Genet."},{"key":"14730_CR81","doi-asserted-by":"publisher","first-page":"e1005865","DOI":"10.1371\/journal.ppat.1005865","volume":"12","author":"CJ Wittkopp","year":"2016","unstructured":"Wittkopp, C. J., Adolph, M. B., Wu, L. I., Chelico, L. & Emerman, M. A single nucleotide polymorphism in human APOBEC3C enhances restriction of lentiviruses. PLoS Pathog. 12, e1005865\u2013e1005865 (2016).","journal-title":"PLoS Pathog."},{"key":"14730_CR82","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1093\/infdis\/174.4.679","volume":"174","author":"RD Burk","year":"1996","unstructured":"Burk, R. D. et al. Sexual behavior and partner characteristics are the predominant risk factors for genital human papillomavirus infection in young women. J. Infect. Dis. 174, 679\u2013689 (1996).","journal-title":"J. Infect. Dis."},{"key":"14730_CR83","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1002\/jmv.10220","volume":"68","author":"PE Castle","year":"2002","unstructured":"Castle, P. E. et al. Comparisons of HPV DNA detection by MY09\/11 PCR methods. J. Med. Virol. 68, 417\u2013423 (2002).","journal-title":"J. Med. Virol."},{"key":"14730_CR84","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jviromet.2007.02.006","volume":"143","author":"ST Dunn","year":"2007","unstructured":"Dunn, S. T., Allen, R. A., Wang, S., Walker, J. & Schiffman, M. DNA extraction: an understudied and important aspect of HPV genotyping using PCR-based methods. J. Virol. Methods 143, 45\u201354 (2007).","journal-title":"J. Virol. Methods"},{"key":"14730_CR85","doi-asserted-by":"publisher","first-page":"6855","DOI":"10.1128\/JVI.00483-12","volume":"86","author":"I Cornet","year":"2012","unstructured":"Cornet, I. et al. Human papillomavirus type 16 genetic variants: phylogeny and classification based on E6 and LCR. J. Virol. 86, 6855\u20136861 (2012).","journal-title":"J. Virol."},{"key":"14730_CR86","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1002\/1097-0215(20000715)87:2<221::AID-IJC11>3.0.CO;2-2","volume":"87","author":"MV Jacobs","year":"2000","unstructured":"Jacobs, M. V. et al. Distribution of 37 mucosotropic HPV types in women with cytologically normal cervical smears: the age-related patterns for high-risk and low-risk types. Int. J. Cancer 87, 221\u2013227 (2000).","journal-title":"Int. J. Cancer"},{"key":"14730_CR87","doi-asserted-by":"publisher","first-page":"80","DOI":"10.4161\/fly.19695","volume":"6","author":"P Cingolani","year":"2012","unstructured":"Cingolani, P. et al. A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w(1118); iso-2; iso-3. Fly 6, 80\u201392 (2012).","journal-title":"Fly"},{"key":"14730_CR88","doi-asserted-by":"publisher","first-page":"2688","DOI":"10.1093\/bioinformatics\/btl446","volume":"22","author":"A Stamatakis","year":"2006","unstructured":"Stamatakis, A. RAxML-VI-HPC: maximum likelihood-based phylogenetic analyses with thousands of taxa and mixed models. Bioinformatics 22, 2688\u20132690 (2006).","journal-title":"Bioinformatics"},{"key":"14730_CR89","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.celrep.2012.12.008","volume":"3","author":"LB Alexandrov","year":"2013","unstructured":"Alexandrov, L. B., Nik-Zainal, S., Wedge, D. C., Campbell, P. J. & Stratton, M. R. Deciphering signatures of mutational processes operative in human cancer. Cell Rep. 3, 246\u2013259 (2013).","journal-title":"Cell Rep."},{"key":"14730_CR90","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780195135848.001.0001","volume-title":"Molecular Evolution and Phylogenetics","author":"M Nei","year":"2000","unstructured":"Nei, M. & Kumar, S. Molecular Evolution and Phylogenetics (Oxford University Press, New York, 2000)."},{"key":"14730_CR91","first-page":"512","volume":"10","author":"K Tamura","year":"1993","unstructured":"Tamura, K. & Nei, M. Estimation of the number of nucleotide substitutions in the control region of mitochondrial DNA in humans and chimpanzees. Mol. Biol. Evol. 10, 512\u2013526 (1993).","journal-title":"Mol. Biol. Evol."},{"key":"14730_CR92","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1093\/molbev\/msw054","volume":"33","author":"S Kumar","year":"2016","unstructured":"Kumar, S., Stecher, G. & Tamura, K. MEGA7: molecular evolutionary genetics analysis version 7.0 for bigger datasets. Mol. Biol. Evol. 33, 1870\u20131874 (2016).","journal-title":"Mol. Biol. Evol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-14730-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-14730-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-14730-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T12:41:17Z","timestamp":1722429677000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-14730-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,14]]},"references-count":92,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["14730"],"URL":"https:\/\/doi.org\/10.1038\/s41467-020-14730-1","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,14]]},"assertion":[{"value":"3 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"886"}}